Biotechnology Market Research Reports & Industry Analysis
While agriculture, material science and environmental science are major areas of research, the largest impact is made in the field medicine. As a large player in the research and development of pharmaceuticals, the role of biotechnology in the healthcare field is undeniable. From genetical analysis and manipulation to the formation of new drugs, many biotech firms are transforming into pharmaceutical and biopharmaceutical leaders.
This research category includes various comprehensive reports on research methods, biotech companies, tools, technologies, and equipment commonly used in the biotech industry. You will also find business reports covering funding, product pipelines, mergers and acquisitions, and strategies for development. The “green” and “white” biotech sectors are also covered in the reports herein.
Biotechnology Industry Research & Market Reports
-
Global Portable Gas Chromatography Market 2018-2022
... Chromatography Market to grow at a CAGR of 5.1% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the portable gas chromatography market. To calculate ... Read More
-
Global Dairy Enzymes Category - Procurement Market Intelligence Report
... shape the production process that can result in the production of cheese and yogurt among other products that are used to improve the texture or flavor of the dairy product. Covered in this report The ... Read More
-
Global Personalized Medicine Market – Types, Technologies and Applications
... integrated with advanced analytics, patient data, customized medicines and other possibilities. Personalized Medicine will transform the entire pharmaceutical value chain, from early development to companies’ go-to-market models, and the next five years will be a ... Read More
-
European Laboratory Informatics Market By Product (LIMS, ELN, LES, EDC, ECM, CDMS, SDMS), Component (Services, Software), Delivery (On Premise, Cloud, Web), End User (Pharma, Biotech, MDx, Biobank, CRO, F&B, Oil, Gas, Chemical) – Forecast To 2024
... to 2024 European laboratory informatics market is expected to reach $1,084.3 million by 2024, growing at a CAGR of 6.4% during the forecast period of 2018 to 2024. Succeeding an extensive secondary and primary research ... Read More
-
2018 Global Molecular Diagnostics and DNA Sequencing Market Country Shares and Sales Segment Forecasts, Laboratory Universe
... Spain, UK and USA. Five-year test volume and sales forecasts by country. Contains 4 pages Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the ... Read More
-
North America Laboratory Informatics Market By Product (LIMS, ELN, LES, EDC, ECM, CDMS, SDMS), Component (Services, Software), Delivery (On Premise, Cloud, Web), End User (Pharma, Biotech, MDx, Biobank, CRO, F&B, Oil, Gas, Chemical) – Forecast To 2024
... Forecast to 2024 North American laboratory informatics market is expected to grow at a CAGR of 6.2% from 2018 to reach $1,715 million by 2024. The growth of this market is mainly attributed to the ... Read More
-
The Biotech Growth Trust Plc (BIOG) - Financial and Strategic SWOT Analysis Review
... to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling ... Read More
-
Global Mass Spectrometry Market, Forecast to 2024
... there is still lot of potential for growth in developing economies in Asia Pacific and Rest of the World. This research service aims to capture the current picture of the global mass spectrometer market, updating ... Read More
-
Downstream Bioprocessing Markets (Chromatography Columns and Resins, Membrane Adsorbers, Filtration Systems, Sensors)
... or plant tissue or fermentation broth. It is an essential step in producing pharmaceuticals, such as antibiotics, hormones (insulin and human growth hormone), antibodies, and vaccines. Downstream Bioprocessing Markets analyzes the current and potential world ... Read More
-
Global Proteomics Partnering 2010-2018
... companies. Trends in Proteomics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Proteomics partnering contract documents Top Proteomics deals by value The Global Proteomics Partnering Terms and Agreements report provides an ... Read More
-
Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018
... to the joint venture deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully ... Read More
-
Global Personalized Medicine in Oncology Partnering Terms and Agreements 2012 to 2018
... personalized medicine in oncology partnering agreements entered into by the worlds leading companies. Comprehensive directory of personalized medicine in oncology deals since 2012 Personalized medicine in oncology contract documents Personalized medicine in oncology agreement terms ... Read More
-
Global Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players and financials
... understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal ... Read More
-
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018
... to the collaborative R&D deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest collaborative R&D deals announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully ... Read More
-
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2018
... transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate, announced in the pharmaceutical, biotechnology and diagnostic sectors. ... Read More
-
Global Pharmacogenomics Partnering Terms and Agreements 2010 to 2018
... into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter pharmacogenomics partnering deals. The majority of deals are discovery or development stage whereby the ... Read More
-
Global Regenerative Medicine Partnering 2012-2018: Deal trends, players, financials and forecasts
... including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in regenerative medicine Deal terms analysis Partnering agreement structure Partnering contract documents ... Read More
-
Global Gene Therapy Partnering Terms and Agreements 2010 to 2018
... the worlds leading healthcare companies. Trends in gene therapy partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Gene therapypartnering contract documents Top gene therapy deals by value The Global Gene Therapy ... Read More
-
Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012-2018
... how and why companies enter clinical stage partnering deals and provides details of the latest clinical agreements announced in the healthcare sector. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight ... Read More
-
Global Bioinformatics Partnering Terms and Agreements 2012 to 2018
... into by the worlds leading healthcare companies. Trends in bioinformatics partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active deal makers Financial deal terms for bioinformatics The ... Read More
-
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018
... to the co-development deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest Co-development agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and ... Read More
-
Global Microbiome Partnering 2012-2018
... companies. Trends in Microbiome partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Microbiome partnering contract documents Top Microbiome deals by value The Global Microbiome Partnering Terms and Agreements report provides an ... Read More
-
Global Genomics Partnering 2010-2018
... companies. Trends in Genomics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Genomics partnering contract documents Top Genomics deals by value The Global Genomics Partnering Terms and Agreements report provides an ... Read More
-
Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012-2018
... why and what terms companies enter preclinical stage partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest preclinical agreements announced in ... Read More
-
Worldwide Biotech October 2018
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry. Read More
